pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Immunology · news · pharmadog
← back to Immunology
News · Immunology
996
stories
3d
STAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issues
stat
3d
Big-name investors pour $100M into DNA therapeutics developer Seawolf
biopharma dive
3d
Aclaris drops TSLP program from pipeline after flunking phase 2 eczema test
fiercebiotech
3d
One of Europe’s leading VCs banks a €725M ‘crossover’ fund
biopharma dive
3d
Deaths, failed trials and other recent setbacks in the autoimmune space
biospace
5d
George Church quits AI startup; Ira Mellman’s immunotherapy fight; and more
endpoints
6d
Argenx is spending billions to push beyond Vyvgart
endpoints
6d
Arrowhead’s Ionis problem, Kyverna’s next-gen end and more biotech earnings
biospace
6d
This week in charts: Brain drugs are back on venture capitalists’ minds
biopharma dive
6d
Regeneron’s POTS antibody curbs heart rate spikes, teeing up Phase 3 trial
biospace
6d
Sanofi-backed Windward hits $225M IPO goal, as Rezera delays listing over ‘market conditions’
fiercebiotech
7d
Windward prices $175M IPO to advance China-licensed lung drugs
biopharma dive
7d
Webinar: Optimizing Cell Therapy Manufacturing Efficiency with Cryopreserved Cells
biospace
7d
Sofinnova books biggest-ever $815M fund with an eye toward up-and-coming ‘global leaders’
fiercebiotech
7d
Bristol Myers research chief to depart in ‘evolution’ of company’s structure
biopharma dive
7d
STAT+: What to know about Biogen’s big lupus study readout
stat
7d
Vor pays RemeGen $10M for long-acting addition to autoimmune pipeline
fiercebiotech
7d
Opinion: I research MAHA and Black Americans. The relationship is complicated — and fascinating
stat
7d
Kyverna abandons next-gen autoimmune CAR-T once touted as follow-up to miv-cel
fiercebiotech
7d
Biopharma layoffs rise YOY in October but sharply trend down for 2026
biospace
8d
AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning
biopharma dive
8d
Valo and Montai become one as the Flagship AI-based biotechs tie the knot
fiercebiotech
8d
Amgen builds Sjögren’s case with detailed phase 3 data ahead of Novartis showdown
fiercebiotech
9d
Why this year’s flu season could be hitting teens and young adults hard
stat
9d
London biotech Oyster harvests $60M for tau-targeting brain drugs
biopharma dive
9d
AbCellera becomes latest biotech to abandon dream of developing OX40 drug
fiercebiotech
9d
Family Farmstead Dairy Announces Recall of All Cheddar Cheese Products Because of Possible Health Risk
fda recalls
9d
BioSpace 2027 Best Places to Work shines light on most admired employers
biospace
9d
Coherus shrinks headcount 30% to narrow focus of cancer combo
fiercebiotech
10d
Argenx to buy peptide platform in potentially billion-dollar deal
biopharma dive
← prev
page 2 of 34
next →